Devaluation and Revaluation as Dynamic Social Processes: The Case of Psychedelic Stigma.
Hannah Farrimond, Mike Michael
Sociology of Health & Illness May 1, 2026 DOI: 10.1111/1467-9566.70200 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper Case report Peer reviewed |
|---|---|
| Keywords | Drugs Legalisation Prejudice Psychedelics Social processes Stigma trajectories Stigmatisation |
| Key points | Proposes that psychedelic drug stigma is undergoing social 'revaluation' due to drivers such as Western biomedicine's interest in psychedelics as therapeutics. |
Abstract
Stigma is a form of social devaluation, eliciting shame, disgust and othering. Most theorisation of stigma has focused on devaluation and stigmatisation; this paper identifies and expands on the concept of 'revaluation', defined as the positive revision of previously derogated social objects as part of ongoing stigma trajectories. To do so, we draw on 'stigma mutation' theory, which highlights three dynamic dimensions of stigma change over time: the lineage or history of the stigma, its variation in diverse groups and contexts and its intensity or strength. We further draw on assemblage theories to explain the dynamism of stigma trajectories where both established and novel connections occur globally and locally beyond traditional group or identity boundaries. To illustrate the processes of revaluation, we present a case study of psychedelic drug stigma, analysing academic texts and media articles. Although psychedelic stigma has embedded lineage within existing illegal drug stigma, it is undergoing social revaluation due to other drivers, such as Western biomedicine's recent interest in psychedelics as therapeutics. It is important to consider the dynamism of devaluation and revaluation processes within stigma trajectories; these may occur simultaneously, in complex ways, as the result of multiple connections in both local and global worlds.
Citations in the library
Cites 15
- Psychedelic Psychiatry's Brave New World. Cell April 1, 2020
- The psychedelic renaissance and the limitations of a White-dominant medical framework: A call for indigenous and ethnic minority inclusion Journal of Psychedelic Studies July 1, 2019
- Psychedelic-Assisted Psychotherapy—A Systematic Review of Associated Psychological Interventions Frontiers in Psychology June 10, 2022
- Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis. Journal of Affective Disorders February 1, 2023
- Making psychedelics into medicines: The politics and paradoxes of medicalization Journal of Psychedelic Studies July 30, 2019
and 10 more in the library